Format

Send to

Choose Destination
Lancet. 2002 Jan 5;359(9300):62-9.

Crohn's disease.

Author information

1
Department of Medicine, Clinical Sciences Building, Cork University Hospital, Cork, Ireland. F.shanahan@ucc.ie

Abstract

Crohn's disease is a disorder mediated by T lymphocytes which arises in genetically susceptible individuals as a result of a breakdown in the regulatory constraints on mucosal immune responses to enteric bacteria. Regulation of immune reactivity to enteric antigens has improved understanding of the pathophysiological mechanisms of Crohn's disease, and has expanded therapeutic options for patients with this disorder. Disease heterogeneity is probable, with various underlying defects associated with a similar pathophysiological outcome. Although most conventional drug treatments are directed at modification of host response, therapeutic manipulation of the enteric flora is becoming a realistic option.

PMID:
11809204
DOI:
10.1016/S0140-6736(02)07284-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center